EU Project Takes ACTION with Bio, Grid and Nano Technology Development

European researchers have forged a partnership with counterparts in the Western Balkans, North Africa and Latin America to strengthen cooperation in the fields of biomedical informatics (BMI), grid technologies and nanoinformatics. Their work is being carried out through ACTION-Grid, a project supported by the EU's Seventh Framework Programme (FP7) with funding totalling some €1 million. ACTION-Grid kicked off in June and will run for a period of 18 months.

The ACTION-Grid consortium aims to maximise the potential of biomedical data and computing resources. The project partners' work effectively reinforces the European Commission's position that research groups improve their understanding of activities carried out in target countries such as those from the Western Balkans and Latin America. The partners will focus on finding and fuelling cooperation, as well as identifying viable activities for the future. Besides establishing a collaborative environment between the regions, the seven-member consortium will exchange research results and contribute to improving the EU's Research Programme in a specific area.

Their work will develop training and mobility in BMI, grid and nanoinformatics. The consortium says the results will be integrated with data from an automated 'resourceome', an inventory of BMI/grid/nano methods and services developed by the ACTION-Grid team. This inventory can be accessed by researchers and users. Ultimately, the resourceome will enable researchers - from the across the board - to access the new technologies developed in the EU.

With support from a panel of recognised experts, the consortium will also develop a White Paper, which will be presented to the EC so as to initiate new plans in the regions in question.

The dissemination of the ACTION-Grid results will be made possible via an international symposium on BMI and grid, as well as scientific publications, newsletters, press releases and a website.

The upshot of the ACTION-Grid project is that major achievements in the fields of BMI and grid computing, including tools, expertise and methods, can be reused and transferred to the Western Balkans, North Africa and Latin America. The knowledge gained in ACTION-Grid will also be incurred from key successes achieved by the consortium in the past. Examples include past EU-backed GRID-based projects, including Gripps, MediGrid, GLOP and eDiamond.

The EU has been relentless in its pursuit over the last 10 years to establish and implement initiatives linking clinical data and results from a myriad of projects, methods and tools in the BMI area. It should be noted that EU research in the areas of genomic and personalised medicine has encouraged scientists to participate in the various research projects that have got off the ground in the region.

Specifically, the link between ACTION-Grid and the field of medicine is nanoinformatics; ACTION-Grid is the EU's maiden project targeting the development of this discipline. The consortium says nanomedicine has the capacity to meliorate existing diagnostic methods and treatments.

Coordinated by the Biomedical Informatics Group at the Madrid Polytechnic University in Spain, ACTION-Grid brings together partners from Argentina, Chile, Croatia, France and Greece.

For further information, please visit:
http://www.action-grid.eu/

Related article:

Copyright ©European Communities, 2008
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

A Novel AI-Based Method Reveals How Cell…

Researchers from Tel Aviv University have developed an innovative method that can help to understand better how cells behave in changing biological environments, such as those found within a cancerous...